Catalyst Wire Dossier Catalyst Wire Dossier

Milademetan

milademetan · Daiichi Sankyo
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Milademetan, covering 2019-02-12 to 2025-01-14. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma [Phase 3]

See pricing